These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Impressive shrinkage of a giant prolactinoma treated with cabergoline in a prepubescent girl. What now? Christoforidis A, Tsakalides C, Anastasiou A, Pavlaki A, Dimitriadou M. Neuro Endocrinol Lett; 2013; 34(4):275-7. PubMed ID: 23803868 [Abstract] [Full Text] [Related]
12. Pathological gambling associated with cabergoline therapy in a patient with a pituitary prolactinoma. Davie M. J Neuropsychiatry Clin Neurosci; 2007; 19(4):473-4. PubMed ID: 18070857 [No Abstract] [Full Text] [Related]
13. Cystic degeneration of macroprolactinoma on long-term cabergoline. Sharif DA, Nkonge FM, Chawda S, Benjamin J, Stojanović ND. J Clin Endocrinol Metab; 2010 Aug; 95(8):3593-4. PubMed ID: 20685886 [No Abstract] [Full Text] [Related]
15. Remarkable effects of cabergoline in a patient with huge prolactinoma resistant to high-dose bromocriptine: case report. Kawabata Y, Ueno Y, Horikawa F, Miyake H, Miki N, Ono M. Surg Neurol; 2008 Jan; 69(1):85-8; discussion 88. PubMed ID: 17967478 [Abstract] [Full Text] [Related]